Operating Profit 更改
Gilead Sciences USD 1.61B 1.01B 2023-12
RedHill Biopharma USD -4408000 33.49M 2023-06
Supernus Pharmaceuticals USD -996000 9.13M 2023-12



Intra Cellular Therapies 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.